International Plasma Protein Congress 2007

Quotes

"An interesting, enjoyable and beneficial event" L. Warren, Alpha One Foundation (Ireland)

"As a first time attendee, the meeting was fantastic!" M. Kevani, KOA Eng. (Iran)

"Great networking opportunities and very good conference" - S. Smith, Canadian Blood Services (Canada)

Sponsors

logodiapharml

Home

Agenda

Please find below the preliminary agenda, we will add session details and speakers as they are confirmed.

Day 1	Tuesday 6 March
09:00 - 09:10	Welcome and introduction Mr. C. Waller, PPTA
09:10 - 09:25	State of the industry Speaker TBC
09:25 - 09:50	Treatment for all Mr. M. Skinner, World Federation of Hemophilia
10:30 - 12:30	Global healthcare developments Chairperson: Dr. E. Bastida, Grifols Healthcare developments in India Dr. S. Singh, Chandigarh hospital, India Healthcare developments in Russia Prof. V Gorodetskiy Global developments Mr. J. Bult, PPTA
12:30 - 14:00	Lunch
14:00 - 15:30	Accessing care for small patient populations Chairperson: Ms. J. Birkofer, PPTA Living with Alpha 1 Deficiency L. Warren, Alpha One Foundation and C. Mayer, Alpha One Austria Patient registries: potential role in post-marketing surveillance Dr. B. Grimbacher, ESID Demonstrating efficacy for small patient population Prof. M. Haase, Paul Ehrlich Institute
15:45 - 17:00	Regulatory issues Chairperson: Ms. M. Calcinai, Kedrion EDQM’s role in global harmonization Dr. J-M. Spieser, Council of Europe Is regulation hindering global availability of plasma proteins? Prof. A. Farrugia, Therapeutics Goods Agency Australia Alternatives to randomized clinical trials Dr. H. Gajek, Baxter BioScience EMEA approach to international harmonization Mrs. G. Silvester, European Medicines Agency
17:30 - 19:00	Hilfenhaus award reception and dinner at Palais Ferstel

Day 2	Wednesday 7 March
06:30	1k run/walk for charity
08:30 - 10:15	Collecting plasma for fractionation Chairperson: Dr. M. Rethwilm, Haema Five-year outlook on plasma volume demand Dr. P. Robert, Marketing Research Bureau Balancing plasma manufacturing with global demand Mr. S. Wada, Biomat Mastering donor recruitment Ms. I. Cramer, Nabi People’s motivation to donate plasma Dr. J. Wallner, University of Vienna
10:45 - 12:00	Challenges of contract fractionation Chairperson: Ms. B. Van Zant, Talecris Biotherapeutics The Canadian experience Mr. I. Mumford, Canadian Blood Services Technical challenges Mr. U.E. Jocham, ZLB Behring WHO perspective Dr. A. Padilla, World Health Organisation Regulatory considerations: Dr. J. Kurz, Ministry of Health Austria
12:00 - 13:30	Lunch
13:30 - 16:00	Patient access to immunoglobulins globally Chairperson: Dr. H. Chapel, John Radcliffe Hospital, Oxford Pharmacoeconomics: the physician perspective Dr. J. Bjorkander, Sahlgrenska University Hospital, Göteborg Pharmacoeconomics: the economist perspective Prof. T. Szucs, University of Zürich, Institut für Sozial und Präventivmedizin IVIG in the developing world Dr. S. Singh, Chandigarh Hospital, India Patient access to care worldwide Mr. D. Watters, International Patient Organisation for Primary Immunodeficiency (IPOPI) European perspectives on IVIG usage Dr. J. Kerr, Paul Ehrlich Institute

Webdesign and hosting by